주식/증권 📉 부정적

CMPX Stock Crashes To Over 2-Year Lows — Why FDA Wants Another Cancer Therapy Trial Before Key Marketing Filing

Yahoo Finance 09/22/2026 02:43:19 PM 29회

요약

The FDA wants Compass to conduct a trial showing Tovecimig can improve overall survival in patients with previously treated, advanced biliary tract cancer.

원문 기사 보기

관련 뉴스

Visa wins approval to establish domestic business in China

10/13/2026

European stocks buck tech-led global rout, bank earnings in focus

10/13/2026

Whitbread Non-GAAP EPS 125.10p, Revenue £1.57B; reaffirms FY outlook

10/13/2026

Goldman Sachs upgrades global equities to overweight, favoring U.S. and Asia

10/13/2026

뉴스 목록으로